FMO5 and chronic granulomatous disease: Patients with chronic granulomatous disease (CGD), an immunodeficiency syndrome caused by disabling mutations of genes encoding the NADPH oxidase subunits [60,61], have an increased susceptibility to fungal and bacterial infections.